DTaP-IPV Vaccination Series: Additional Doses Required
After completing three infant doses of DTaP-IPV in the first year (at 2,4, and 6 months), two additional doses are required: a fourth dose at 15-18 months and a fifth dose at 4-6 years of age. 1
Complete Five-Dose Series Overview
The routine DTaP vaccination schedule comprises five total doses for children under 7 years of age 1:
- Doses 1-3 (Primary Series): Administered at 2,4, and 6 months during the first year 1
- Dose 4 (First Booster): Given at 15-18 months of age 1
- Dose 5 (Second Booster): Administered at 4-6 years of age 1
Critical Timing Requirements
Fourth Dose (15-18 Months)
- Must be given at least 6 months after the third dose 1
- May be administered as early as 12 months if the 6-month interval is maintained and the clinician believes a later opportunity may be missed 1
- This dose is essential for maintaining adequate immunity during preschool years 1
Fifth Dose (4-6 Years)
- Required to confer continued protection during early school years 1
- Exception: A fifth dose is not necessary if the fourth dose was administered on or after the fourth birthday 1
- The minimum interval from dose 4 to dose 5 should be at least 6 months to provide optimal booster response 1
IPV-Specific Considerations
For the inactivated poliovirus component, the schedule differs slightly 1:
- Standard 4-dose IPV series: Administered at 2,4,6-18 months, and 4-6 years 1
- The final IPV dose must be given at age ≥4 years regardless of the number of previous doses 1
- Minimum interval from dose 3 to dose 4 is 6 months (not 4 weeks) 1
Special Situation with Combination Vaccines
If using DTaP-IPV/Hib (Pentacel) for all four infant/toddler doses at 2,4,6, and 15-18 months, a fifth dose of IPV-containing vaccine is required at 4-6 years 1. This results in a 5-dose IPV series, which is considered acceptable 1.
Common Pitfalls to Avoid
- Do not skip the fourth dose: Even though three doses provide good initial protection (83.5% effectiveness at 6-11 months), protection wanes significantly without the fourth dose, dropping to 59.2% by 3-4 years of age 2
- Do not administer the fifth dose too early: If given before age 4 years, it will not count as the final dose and another dose will be required 1
- Ensure proper intervals: Undervaccination (missing doses) increases pertussis risk 3-5 fold, while short delays with complete doses are less problematic 3
- Remember the 6-month rule for dose 4: The fourth dose must be at least 6 months after the third dose, even if the child is already 15-18 months old 1
Clinical Significance
Completing all five doses is critical for sustained protection 3, 2. Studies demonstrate that undervaccination significantly increases pertussis risk (adjusted relative risk of 4.8 for incomplete primary series, 3.2 for missing first booster, and 4.6 for missing second booster) 3. The effectiveness of three doses alone wanes from 83.5% at 6-11 months to only 59.2% by 3-4 years without the booster doses 2.